BELLE Capital

Joylux is a health and wellness company that specializes in women's health and wellness. The company is committed to finding scientific solutions that are noninvasive, effective, and affordable to help improve all aspects of a woman’s intimate life. The company was founded in 2013 and headquartered in Seattle, Washington.

TO THE MARKET is the turn key solution for ethical manufacturing and sourcing of apparel, accessories and home goods. Through our syndicated network of suppliers, we work with Fortune 500s, brands and retailers to provide story-rich products that appeal to the next generation of consumers with transparency, sustainability and authenticity. We enable the supply chain of the future, in which retail manufacturing empowers people, protects the planet, and delivers quality products that result in a better bottom line.

TO THE MARKET is the turn key solution for ethical manufacturing and sourcing of apparel, accessories and home goods. Through our syndicated network of suppliers, we work with Fortune 500s, brands and retailers to provide story-rich products that appeal to the next generation of consumers with transparency, sustainability and authenticity. We enable the supply chain of the future, in which retail manufacturing empowers people, protects the planet, and delivers quality products that result in a better bottom line.

Joylux is a health and wellness company that specializes in women's health and wellness. The company is committed to finding scientific solutions that are noninvasive, effective, and affordable to help improve all aspects of a woman’s intimate life. The company was founded in 2013 and headquartered in Seattle, Washington.

Digsite, Inc. develops a platform for online insight communities that improve on outdated online focus group technology. Its platform enables moderators to start public or private discussions, upload images and videos, and use survey and mark-up tools; and participants to add their own comments and discussions. The company also provides SmartReporting, which enables marketers and brand managers to bring qualitative research results to life. Digsite, Inc. was founded in 2014 and is based in Madison, Wisconsin.

Current Motor fills the unmet need for fast, fun, affordable, zero-emission, electric vehicles (EVs). Current Motor develops and manufactures all-electric maxi-scooters for the Americas, made in Michigan. The company’s EVs use no gas, produce no emissions and create no maintenance hassles. Their maxi-scooters offer speeds up to 70 MPH and a range of up to 50 miles. They charge from a standard 110V household outlet in 5 hours. Backed by BELLE Capital, the State of Michigan and other private equity investors, please visit www.currentmotor.com for more information. They are shipping Test Pilot (beta) bikes with full production maxi-scooters scheduled to ship at the end of the 2011.

Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

Vital Vio offers a new class of antimicrobial light for infection and germ control through safe, continuous LED products. Our goal is to protect as many people and places from germs as possible with our products which can be utilized anywhere a light can fit. We service customers in food processing, healthcare, industrial/commercial as well as a licensing model for consumer and residential products.

Cardialen, Inc., a medical device company that develops a therapy system that detects and treats atrial fibrillation, rapid ventricular tachycardia, and ventricular fibrillation. It offers an implantable device to restore normal heart rhythm and may reduce the potential for high-energy defibrillation shocks. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.

Ocuphire Pharma is a clinical-stage biopharmaceutical company committed to the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. We are currently focused on providing a novel once-daily eye drop treatment option, Nyxol®, to treat multiple front-of-the-eye disorders, including night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage clinical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of our strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes, and to seek strategic partners for global commercialization.